Literature DB >> 15634882

LIGHT is constitutively expressed on T and NK cells in the human gut and can be induced by CD2-mediated signaling.

Offer Cohavy1, Jaclyn Zhou, Carl F Ware, Stephan R Targan.   

Abstract

The TNF superfamily cytokine, lymphotoxin-like inducible protein that competes with glycoprotein D for binding herpesvirus entry mediator on T cells (LIGHT; TNFSF14), can augment T cell responses inducing IFN-gamma production and can drive pathological gut inflammation when expressed as a transgene in mouse T cells. LIGHT expression by human intestinal T cells suggests the possibility that LIGHT may play a key role in regulation of the mucosal immune system. A nonenzymatic method was developed for the isolation of T cells from the human lamina propria, permitting analysis of native cell surface protein expression. Cell surface LIGHT was constitutively expressed on mucosal T and NK cells and a subpopulation of gut-homing CD4(+) T cells in the periphery. In addition, CD2-mediated stimulation induced efficient LIGHT expression on intestinal CD4(+) T cells, but not on peripheral blood T cells, suggesting a gut-specific, Ag-independent mechanism for LIGHT induction. By contrast, herpesvirus entry mediator expression on gut T cells was unperturbed, implicating the transcriptional regulation of LIGHT as a mechanism modulating signaling activity in the gut. Quantitative analysis of LIGHT mRNA in a cohort of inflammatory bowel disease patients indicated elevated expression in biopsies from small bowel and from inflamed sites, implicating LIGHT as a mediator of mucosal inflammation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15634882     DOI: 10.4049/jimmunol.174.2.646

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

Review 1.  Lymphoid organogenesis in the intestine.

Authors:  Rebekah T Taylor; Ifor R Williams
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 2.  Immunopathogenesis of inflammatory bowel disease.

Authors:  David Q Shih; Stephan R Targan
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

Review 3.  Immunoregulation by tumor necrosis factor superfamily member LIGHT.

Authors:  Yugang Wang; Mingzhao Zhu; Mendy Miller; Yang-Xin Fu
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

Review 4.  Regulating the mucosal immune system: the contrasting roles of LIGHT, HVEM, and their various partners.

Authors:  Marcos W Steinberg; Jr-Wen Shui; Carl F Ware; Mitchell Kronenberg
Journal:  Semin Immunopathol       Date:  2009-06-03       Impact factor: 9.623

5.  Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin.

Authors:  Carmelo Luci; Ana Reynders; Ivaylo I Ivanov; Celine Cognet; Laurent Chiche; Lionel Chasson; Jean Hardwigsen; Esperanza Anguiano; Jacques Banchereau; Damien Chaussabel; Marc Dalod; Dan R Littman; Eric Vivier; Elena Tomasello
Journal:  Nat Immunol       Date:  2008-11-23       Impact factor: 25.606

Review 6.  Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways.

Authors:  Carl F Ware
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

Review 7.  The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation.

Authors:  Marcos W Steinberg; Timothy C Cheung; Carl F Ware
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

8.  NK but not CD1-restricted NKT cells facilitate systemic inflammation during polymicrobial intra-abdominal sepsis.

Authors:  Anthony O Etogo; Jesus Nunez; Cheng Y Lin; Tracy E Toliver-Kinsky; Edward R Sherwood
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

Review 9.  Heterogeneous memory T cells in antiviral immunity and immunopathology.

Authors:  David Verhoeven; John R Teijaro; Donna L Farber
Journal:  Viral Immunol       Date:  2008-06       Impact factor: 2.257

10.  A novel mucosal RORγtNKp46 cell subset is a source of interleukin-22.

Authors:  Elena Tomasello; Ana Reynders; Eric Vivier
Journal:  F1000 Biol Rep       Date:  2009-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.